Major depressive disorder Trials in Farmington, United States
Conditions / Major depressive disorder / Farmington, United States
Clinical trials for Major depressive disorder investigate a range of treatment strategies and patient populations.
20 total trials for this combination
Showing top 10 of 20 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT01309542 | Long-Term Safety Of DVS-233 SR In Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT00278941 | Quetiapine Fumarate as Monotherapy in the Maintenance Treatment of Patients With Major Depressive Disorder | COMPLETED | PHASE3 |
| NCT06966401 | Long-Term Study to Assess the Safety and Tolerability of NBI-1065845 as an Adjunctive Treatment in Participants With Major Depressive Disorder (MDD) | RECRUITING | — |
| NCT00135421 | Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder | COMPLETED | PHASE1/PHASE2 |
| NCT06419608 | Efficacy and Safety Study of BHV-7000 Monotherapy in Major Depression | COMPLETED | PHASE2 |
| NCT06423781 | Long-term Safety Study of BHV-7000 in Participants With Major Depressive Disorder (MDD) | ENROLLING_BY_INVITATION | PHASE2 |
| NCT06011577 | Randomized, Double-Blind, Placebo-Controlled Trial of REL-1017 as Adjunctive Treatment for MDD | TERMINATED | PHASE3 |
| NCT00320372 | Treatment-Resistant Depression Registry | COMPLETED | — |
| NCT05850689 | Study of Lumateperone as Adjunctive Therapy in the Treatment of Patients With Major Depressive Disorder | RECRUITING | PHASE3 |
| NCT00095745 | A Long-Term Study of Aripiprazole in Patients With Major Depressive Disorder | COMPLETED | PHASE3 |